Table 3.

Crude and standardised rates of mortality by both sex, period of initiation, and period of follow-up

	1996–99	2000–02	2003–05
Crude mortality rates
Initiated 1996–99	16·3 (14·9–17·8)*	11·4 (10·4–12·4)	9·9 (8·9–11·0)
Initiated 2000–02		14·7 (13·2–16·5)*	8·7 (7·7–9·8)
Initiated 2003–05			13·3 (11·5–15·4)*
Standardised mortality rates†
Initiated 1996–99	12·9 (11·8–14·2)*	9·2 (8·4–10·0)	8·1 (7·2–9·1)
Initiated 2000–02		11·1 (9·9–12·5)*	6·7 (5·9–7·6)
Initiated 2003–05			10·3 (8·9–12·0)*

Data are deaths per 1000 person-years (95% CI).

^*Follow-up restricted to the same period during which combination therapy was initiated.

^†Standardised rates were internally standardised by age at initiation of combination therapy, presumed mode of transmission (injecting drug use vs other), and CD4 cell count.